Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHARLES E ARGOFF

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1073673125
CMS profile
93628
Location
ALBANY, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$180,509.15

157 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $41,896.17 68
Allergan, Inc. $38,078.00 37
Teva Pharmaceuticals USA, Inc. $33,561.43 17
Amgen Inc. $21,413.77 18
GRT US Holding, Inc. $12,435.82 1
VERTEX PHARMACEUTICALS INCORPORATED $12,325.00 3
Lundbeck LLC $10,307.00 3
SK Life Science, Inc. $3,200.00 1
Biohaven Pharmaceuticals, Inc. $3,000.00 2
Novartis Pharmaceuticals Corporation $2,534.00 2
Nevro Corp. $800.00 1
US WorldMeds, LLC $500.00 1
Pacira Pharmaceuticals Incorporated $344.00 1
Boston Scientific Corporation $113.96 2

Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHARLES E ARGOFF

NPI 1073673125 · CMS profile ID 93628

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

ALBANY, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1073673125?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHARLES E ARGOFF, NPI 1073673125, CMS profile ID 93628. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1073673125?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). CHARLES E ARGOFF, NPI 1073673125, CMS profile ID 93628. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1073673125?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
CHARLES E ARGOFF, NPI 1073673125, CMS profile ID 93628, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 157 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1073673125?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

157 matching records · $180,509.15 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 157 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 157.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $1,100.0007/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728375133 CMS
Lundbeck LLC $2,660.0007/14/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747499167 CMS
Lilly USA, LLC $1,100.0007/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728357991 CMS
Amgen Inc. $450.0006/26/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740960143 CMS
Pacira Pharmaceuticals Incorporated $344.0006/22/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747919673 CMS
GRT US Holding, Inc. $12,435.8206/19/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746212311 CMS
Lilly USA, LLC $1,100.0006/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728358003 CMS
Teva Pharmaceuticals USA, Inc. $2,500.0006/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749521769 CMS
Lilly USA, LLC $1,100.0006/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728361443 CMS
Allergan, Inc. $1,800.0006/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336353 CMS
Lilly USA, LLC $1,100.0006/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728357999 CMS
Lilly USA, LLC $200.0006/08/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728358001 CMS
SK Life Science, Inc. $3,200.0006/04/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 733066313 CMS
VERTEX PHARMACEUTICALS INCORPORATED $425.0005/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737096449 CMS
Allergan, Inc. $1,800.0005/22/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336349 CMS
Teva Pharmaceuticals USA, Inc. $2,500.0005/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749521771 CMS
Allergan, Inc. $300.0005/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336345 CMS
Allergan, Inc. $400.0004/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336341 CMS
Allergan, Inc. $400.0004/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336337 CMS
Teva Pharmaceuticals USA, Inc. $932.0004/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749521777 CMS
Teva Pharmaceuticals USA, Inc. $1,300.0004/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749521781 CMS
Lilly USA, LLC $2,475.0003/20/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728382163 CMS
US WorldMeds, LLC $500.0003/20/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749608333 CMS
Amgen Inc. $105.1103/17/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740960127 CMS
Amgen Inc. $6.4603/17/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740960139 CMS
Amgen Inc. $2,700.0003/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740960133 CMS
Amgen Inc. $450.0003/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740960137 CMS
Teva Pharmaceuticals USA, Inc. $3,125.0003/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749521765 CMS
Teva Pharmaceuticals USA, Inc. $3,438.0003/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749521785 CMS
Amgen Inc. $2,250.0003/11/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740960145 CMS
Teva Pharmaceuticals USA, Inc. $16.4303/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749521767 CMS
Allergan, Inc. $82.9703/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336325 CMS
Allergan, Inc. $3,000.0003/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336329 CMS
Allergan, Inc. $7.4803/10/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336333 CMS
Amgen Inc. $2,250.0003/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740960129 CMS
Amgen Inc. $69.5303/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740960123 CMS
Allergan, Inc. $3,000.0003/04/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336315 CMS
Allergan, Inc. $5.0603/04/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336319 CMS
Allergan, Inc. $110.9303/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723336322 CMS
Boston Scientific Corporation $70.2402/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725455027 CMS
Novartis Pharmaceuticals Corporation $2,533.0002/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725524817 CMS
Novartis Pharmaceuticals Corporation $1.0002/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725524827 CMS
Lilly USA, LLC $12.0002/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728368347 CMS
Lilly USA, LLC $2,200.0002/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728381913 CMS
Lilly USA, LLC $1,650.0002/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728381915 CMS
Teva Pharmaceuticals USA, Inc. $3.9902/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749449971 CMS
VERTEX PHARMACEUTICALS INCORPORATED $10,625.0002/19/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737096401 CMS
Lilly USA, LLC $551.6502/18/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728364881 CMS
Lilly USA, LLC $18.3402/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728364891 CMS
Lilly USA, LLC $10.7002/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728364893 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $225,786.41 275
PY2020 $180,509.15 157
PY2021 $203,081.18 165
PY2022 $189,323.58 213
PY2023 $163,278.68 134
PY2024 $84,852.87 138
PY2025 $161,021.84 212

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $58,333.06 20
PY2024 Principal investigator $199,087.01 48
PY2023 Principal investigator $107,973.52 44
PY2022 Recipient $6,173.63 10
PY2022 Principal investigator $28,422.93 60
PY2021 Recipient $490.00 1
PY2021 Principal investigator $63,874.13 69
PY2020 Principal investigator $59,075.01 23
PY2019 Recipient $947.00 1
PY2019 Principal investigator $15,138.15 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,854.00 12/31/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
A Phase 3 Multicenter 24-Week Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Atogepant When Added to OnabotulinumtoxinA (BOTOX) for the Preventive Treatment of Chronic Migraine No dispute reported 06/30/2026 1202535123
Principal investigator 1 H. Lundbeck A S $1,449.00 10/15/2025 Covered Recipient Teaching Hospital
ALBANY MEDICAL CENTER HOSPITAL
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications No dispute reported 06/30/2026 1251765104
Principal investigator 1 Purdue Pharma L.P. $518.00 09/18/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011333
Principal investigator 1 Purdue Pharma L.P. $1,332.00 09/18/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011337
Principal investigator 1 H. Lundbeck A S $11,000.00 07/18/2025 Covered Recipient Teaching Hospital
ALBANY MEDICAL CENTER HOSPITAL
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications No dispute reported 06/30/2026 1251765095
Principal investigator 1 H. Lundbeck A S $2,700.00 07/18/2025 Covered Recipient Teaching Hospital
ALBANY MEDICAL CENTER HOSPITAL
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications No dispute reported 06/30/2026 1251765099
Principal investigator 1 ABBVIE INC. $1,350.00 07/10/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1202498000
Principal investigator 1 Purdue Pharma L.P. $1,056.00 06/19/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011327
Principal investigator 1 Purdue Pharma L.P. $4,411.09 06/19/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011329
Principal investigator 1 Purdue Pharma L.P. $554.40 06/19/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011331
Principal investigator 1 Purdue Pharma L.P. $924.00 06/05/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011335
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $2,268.00 03/25/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of VX-548 in Subjects With Painful Lumbosacral Radiculopathy No dispute reported 06/30/2026 1214124170
Principal investigator 1 Purdue Pharma L.P. $1,221.00 03/20/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011323
Principal investigator 1 Purdue Pharma L.P. $3,485.24 03/20/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011325
Principal investigator 1 ABBVIE INC. $67.50 02/27/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
M22-418 - Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1202454557
Principal investigator 1 Purdue Pharma L.P. $858.00 02/06/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011317
Principal investigator 1 Purdue Pharma L.P. $1,122.00 02/06/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011319
Principal investigator 1 Purdue Pharma L.P. $3,123.12 02/06/2025 Non-covered Recipient Entity
Albany Medical College
PMR 3033-11: Study 11 No dispute reported 06/30/2026 1239011321
Principal investigator 1 ABBVIE INC. $2,700.00 01/02/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
M22-418 - Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1202435505
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $16,339.71 01/01/2025 Non-covered Recipient Entity
ALBANY MEDICAL COLLEGE
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of Suzetrigine in Subjects With Painful Diabetic Peripheral Neuropathy No dispute reported 06/30/2026 1214124440